Lipocine Inc. Contracts & Agreements

Third Amended & Restated Rights Agreement, dated October 22, 2024 (Filed With SEC on October 23, 2024)

Lipocine Inc. Fifth Amended and Restated 2014 Stock and Incentive Plan (Filed With SEC on June 3, 2024)

Sales Agreement dated April 26, 2024 by and between Lipocine Inc., and A.G.P./Alliance Global Partners (Filed With SEC on April 26, 2024)

License Agreement dated January 12, 2024 by and among Lipocine, Inc., Gordon Silver Limited, and Verity Pharmaceuticals (Filed With SEC on March 7, 2024)

First Amendment to License Agreement, dated October 14, 2021, made by and among Lipocine Inc., and Antares Pharma, Inc (Filed With SEC on May 9, 2022)

Description of Registered Securities (Filed With SEC on March 9, 2022)

Employment Agreement between Krista Fogarty and Lipocine Inc. dated March 7, 2022 (Filed With SEC on March 7, 2022)

License Agreement, dated October 14, 2021, by and between Lipocine Inc. and Antares Pharma, Inc (Filed With SEC on November 10, 2021)

Amendment No. 1 to Commercial Manufacturing Services and Supply Agreement between Lipocine Inc. and MW Encap Ltd. dated October 13, 2021 (Filed With SEC on November 10, 2021)

First Amendment to Loan and Security Agreement, dated February 16, 2021, made by and among Lipocine Inc., Lipocine Operating Inc. and Silicon Valley Bank (Filed With SEC on February 18, 2021)

Underwriting Agreement, dated January 26, 2021, by and between Lipocine Inc. and Raymond James & Associates, Inc (Filed With SEC on January 27, 2021)

Description of Registered Securities (Filed With SEC on March 13, 2020)

Form of Warrant (Filed With SEC on February 26, 2020)

Placement Agency Agreement, dated as of February 25, 2020, by and between Lipocine, Inc. and Roth Capital Partners, LLC (Filed With SEC on February 26, 2020)

Securities Purchase Agreement, dated as of February 25, 2020, by and between Lipocine, Inc. and the purchasers identified on the signature pages thereto (Filed With SEC on February 26, 2020)

Form of Common Warrant (Filed With SEC on November 14, 2019)

Form of Pre-Funded Warrant (Filed With SEC on November 14, 2019)

Placement Agency Agreement, dated as of November 14, 2019, by and between Lipocine, Inc. and Roth Capital Partners, LLC (Filed With SEC on November 14, 2019)

Securities Purchase Agreement, dated as of November 14, 2019, by and between Lipocine, Inc. and the purchasers identified on the signature pages thereto (Filed With SEC on November 14, 2019)

Employment and Severance Agreement of Nachiappan Chidambaram (Filed With SEC on November 7, 2018)

Amended and Restated Stockholder Rights Plan (Filed With SEC on November 7, 2018)

Third Amended and Restated Lipocine Inc. 2014 Stock and Incentive (Filed With SEC on August 7, 2018)

Loan and Security Agreement dated January 5, 2018 (Filed With SEC on January 9, 2018)

LIPOCINE INC. Shares of Common Stock (par value $0.0001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on March 6, 2017)

SECOND AMENDED AND RESTATED EXECUTIVEEMPLOYMENT AGREEMENT for Morgan Brown (Filed With SEC on March 6, 2017)

EXECUTIVE EMPLOYMENT AGREEMENT for Gregory Bass (Filed With SEC on March 6, 2017)

SECONDamended and restated LIPOCINE INC. 2014 stock and INCENTIVE PLAN (Filed With SEC on August 9, 2016)

COMMERCIAL MANUFACTURING SERVICES ANDSUPPLY AGREEMENT (Filed With SEC on May 9, 2016)

LIPOCINEINC. and AMERICANSTOCK TRANSFER & TRUST COMPANY, LLC, as Rights Agent RIGHTSAGREEMENT Datedas of November 13, 2015 (Filed With SEC on November 13, 2015)

EXECUTIVE EMPLOYMENT AGREEMENT for Dr. Jyrki Mattila (Filed With SEC on August 11, 2015)

Lipocine Inc. 4,650,000Shares Common Stock Underwriting Agreement (Filed With SEC on April 24, 2015)

SEPARATION AND RELEASE AGREEMENT (Filed With SEC on November 19, 2014)

LipocineInc. RestrictedStock Unit Grant Notice 2011Equity Incentive Plan (Filed With SEC on March 31, 2014)

Exhibit 10.4 EXECUTIVE EMPLOYMENT AGREEMENT for Dr. Srinivasan Venkateshwaran (Filed With SEC on January 7, 2014)

Exhibit 10.1 EXECUTIVE EMPLOYMENT AGREEMENT for Mahesh V. Patel (Filed With SEC on January 7, 2014)

Exhibit 10.2 AMENDED AND RESTATED EXECUTIVE EMPLOYMENTAGREEMENT for Morgan Brown (Filed With SEC on January 7, 2014)

Exhibit 10.3 EXECUTIVE EMPLOYMENT AGREEMENT for Gerald Simmons (Filed With SEC on January 7, 2014)

UNDERWRITING AGREEMENT between LIPOCINE INC. and LADENBURG THALMANN & CO. INC. as Representative of the Several Underwriters LIPOCINE INC. UNDERWRITING AGREEMENT (Filed With SEC on November 21, 2013)

EXECUTIVE EMPLOYMENT AGREEMENT for Morgan Brown (Filed With SEC on September 18, 2013)

Agreement for the Manufacture of Testosterone Undecanoate Liquid Fill Capsules and the Conduct of an ICH Stability Study in Support of Product Registration with Lipocine, Inc.... (Filed With SEC on September 5, 2013)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on July 31, 2013)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on July 31, 2013)

LIPOCINE INC. REGISTRATION RIGHTS AGREEMENT (Filed With SEC on July 25, 2013)

LIPOCINE INC. SERIES B COMMON STOCK PURCHASE WARRANT (Filed With SEC on July 25, 2013)

DIRECTOR AND OFFICER INDEMNIFICATION AGREEMENT (Filed With SEC on July 25, 2013)

SECOND LEASE EXTENSION AND MODIFICATION AGREEMENT (Filed With SEC on July 25, 2013)

ASSIGNMENT AND ASSUMPTION OF LEASE (Filed With SEC on July 25, 2013)

LIPOCINE INC. 2011 EQUITYINCENTIVE PLAN RESTRICTED STOCK AWARDAGREEMENT (Filed With SEC on July 25, 2013)

LIPOCINE INC. 2011 EQUITYINCENTIVE PLAN OPTION AGREEMENT (INCENTIVE STOCK OPTION OR NONSTATUTORY STOCKOPTION) (Filed With SEC on July 25, 2013)

LIPOCINE INC. AMENDEDAND RESTATED 2011 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OFDIRECTORS: DECEMBER 17, 2010 APPROVED BYTHE STOCKHOLDERS: FEBRUARY 4, 2011 TERMINATIONDATE:... (Filed With SEC on July 25, 2013)

AGREEMENT AND PLAN OF MERGER AND REORGANIZATION (Filed With SEC on July 25, 2013)

Category

Industry

Companies

Contracts

Lipocine Inc. Contracts & Agreements